Using a database of OPAT patients’ clinical histories, researchers found aminoglycoside use was most strongly tied to higher odds of readmission, followed by infection from resistant organisms, prior hospital discharges and, lastly, older age. Twenty-six percent of OPAT-prescribed patients were readmitted.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
Researchers suggest certain clinical characteristics can flag patients at risk for readmission at discharge, and interventions for OPAT patients should be developed to help curb readmission numbers.
More Articles on Readmissions:
Reducing Hospital Readmissions Rates: How to Avoid Upcoming Penalties and Maintain Patient Wellness
6 Stats on the Cost of Readmission for CMS-Tracked Conditions
5 Stories, Studies on Hospital Readmission Rates
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.